Development of hepatocellular carcinoma long after sustained viral response to interferon therapy in patients with chronic hepatitis C - Fat accumulation may contribute to the carcinogenesis

被引：0
|
作者：
Kurihara, H [1 ]
Tanaka, A [1 ]
Uegaki, S [1 ]
Aida, J [1 ]
Nagashima, I [1 ]
Shiga, J [1 ]
机构：
[1] Teikyo Univ, Sch Med, Tokyo 173, Japan
来源：
HEPATOLOGY | 2005年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：389A / 389A
页数：1
相关论文
共 50 条
  • [21] The incidence of hepatocellular carcinoma in patients with chronic hepatitis C who achieved sustained virological response to interferon therapy
    Kobayashi, S.
    Enomoto, M.
    Tamori, A.
    Kawada, N.
    Habu, D.
    Sakaguchi, H.
    Takedal, T.
    Nishiguchi, S.
    Seki, S.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S219 - S219
  • [22] Sustained response after alpha interferon therapy in patients with chronic hepatitis C
    Boyer, N
    Marcellin, P
    Duchatelle, V
    Martinot, M
    Kilani, A
    Pouteau, M
    Descombes, I
    Benhamou, JP
    Degott, C
    Erlinger, S
    HEPATOLOGY, 1996, 23 (01) : P101 - P101
  • [23] Incidence of hepatocellular carcinoma after interferon therapy in patients with chronic hepatitis C
    Onodera, H
    Ukai, K
    Suzuki, M
    Minami, Y
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 181 (02): : 275 - 283
  • [24] Hepatic iron accumulation is an independent risk factor for the development of hepatocellular carcinoma after interferon therapy in patients with chronic hepatitis C
    Izumi, N
    Asahina, Y
    Uchihara, M
    Osamu, N
    Kanazawa, N
    Itakura, J
    Miyake, S
    Sakai, T
    GASTROENTEROLOGY, 2001, 120 (05) : A77 - A77
  • [25] Interferon therapy prevents the development of hepatocellular carcinoma in chronic hepatitis C patients?
    Okanoue, T
    Itoh, Y
    Minami, M
    Sakamoto, S
    Katagishi, T
    Nishioji, K
    Miyoshi, M
    Sawa, Y
    Nakagawa, Y
    Tada, H
    Kashima, K
    HEPATOLOGY, 1996, 24 (04) : 1082 - 1082
  • [26] Development of Hepatocellular Carcinoma in Chronic Hepatitis C Patients 20 Years after Achieving a Sustained Virological Response with Interferon Therapy: A Report of Two Cases
    Igarashi, Go
    Endo, Tetsu
    Sawada, Naoya
    Mikami, Kenichiro
    Sato, Ken
    Kudo, Daisuke
    Toyoki, Yoshikazu
    Hakamada, Kenichi
    Kakuta, Akihisa
    Shibutani, Koichi
    Takai, Yoshihiro
    Yoshizawa, Tadashi
    Haga, Toshihiro
    Kijima, Hiroshi
    Fukuda, Shinsaku
    JOURNAL OF GENERAL AND FAMILY MEDICINE, 2015, 16 (03): : 199 - 203
  • [27] Impact of sustained virological response to interferon therapy for chronic hepatitis C on recurrence and long-term survival in patients with hepatocellular carcinoma
    Shinkawa, H.
    Hasegawa, K.
    Arita, J.
    Akamatsu, N.
    Kaneko, J.
    Sakamoto, Y.
    Kokudo, N.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S443 - S444
  • [28] Characteristics and prognosis of hepatocellular carcinoma after sustained virological response to interferon therapy for hepatitis C
    Honda, Koichi
    Seike, Masataka
    Oribe, Junya
    Endo, Mizuki
    Yoshihara, Mie
    Syo, Hiroki
    Iwao, Masao
    Tokoro, Masanori
    Mori, Tetsu
    Yamashita, Tsutomu
    Muro, Toyokichi
    Murakami, Kazunari
    HEPATOLOGY, 2014, 60 : 873A - 874A
  • [29] Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy
    Tokita, H
    Fukui, H
    Tanaka, A
    Kamitsukasa, H
    Yagura, M
    Harada, H
    Okamoto, H
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 20 (05) : 752 - 758
  • [30] Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy
    Iwasaki, Y
    Takaguchi, K
    Ikeda, H
    Makino, Y
    Araki, Y
    Ando, M
    Kobashi, H
    Kobatake, T
    Tanaka, R
    Tomita, M
    Senoh, T
    Kawaguchi, M
    Shimoe, T
    Manabe, K
    Kita, K
    Shimamura, J
    Sakaguchi, K
    Shiratori, Y
    LIVER INTERNATIONAL, 2004, 24 (06) : 603 - 610
12345